5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery
Hydrophilic derivatives of an earlier described series of carbonic anhydrase inhibitors have been designed, prepared and profiled against a panel of carbonic anhydrase isoforms, including the glaucoma-related hCA II. For all hydrophilic derivatives, computational prediction of intraocular permeabili...
Saved in:
Main Authors: | Stanislav Kalinin (Author), Alexander Kovalenko (Author), Annika Valtari (Author), Alessio Nocentini (Author), Maxim Gureev (Author), Arto Urtti (Author), Mikhail Korsakov (Author), Claudiu T. Supuran (Author), Mikhail Krasavin (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
by: Tatiana Sharonova, et al.
Published: (2022) -
Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases
by: Mikhail Krasavin, et al.
Published: (2017) -
Study of biotransformation of new selective carbonic anhydrase II inhibitor 4-(2-methyl-1,3-oxazole-5-yl)-benzenesulfonamide
by: A. L. Khokhlov, et al.
Published: (2023) -
Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida®) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms
by: Claudiu T. Supuran, et al.
Published: (2021) -
Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents
by: Mikhail Krasavin, et al.
Published: (2020)